SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-077213
Filing Date
2020-03-18
Accepted
2020-03-18 16:43:03
Documents
5
Period of Report
2020-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d888884d8k.htm 8-K 28419
2 EX-1.1 d888884dex11.htm EX-1.1 167396
3 EX-5.1 d888884dex51.htm EX-5.1 13398
4 GRAPHIC g888884dsp40.jpg GRAPHIC 4515
5 GRAPHIC g888884g0317011353325.jpg GRAPHIC 1843
  Complete submission text file 0001193125-20-077213.txt   219491
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 20725120
SIC: 2834 Pharmaceutical Preparations